ReviewJournal for immunotherapy of cancer2024

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.